The excessive cardiovascular mortality associated with diabetes mellitus represents a severe and unacceptable burden for afflicted individuals both nationally and worldwide. The reasons underlying the excess cardiovascular mortality in diabetes include: 1) accelerated atherosclerosis; 2) ventricular contractile dysfunction resulting from metabolic abnormalities in cardiac myocytes; and 3) an increased susceptibility of diabetic myocardium to acute ischemia. The magnitude of these diverse myocardial and vascular sequelae of diabetes are directly related to the severity and duration of hyperglycemia itself suggesting a direct relationship of alterations in glucose metabolism to these end-organ effects. Recently, our laboratory has identified a novel metabolic paradigm in which glycolytic flux is coupled to the generation of lipid second messengers by regulating the activity of a calcium- independent phospholipase A2 catalytic complex. Accordingly, the unifying hypothesis embodying this program project is that the vascular and myocardial sequelae of diabetes mellitus are fundamentally interrelated through this metabolic paradigm and result directly from the dysfunctional regulation of lipid second messenger generation in diabetic tissues. In Project 1 the role of altered glycolytically coupled activation of calcium-independent phospholipase A2 in myocardium will be explored with emphasis on the contractile dysfunction manifest in diabetic myocardium and the increased susceptibility of diabetic myocardium to ischemic injury. In Project 2 the role of increased glycolytic flux and augmented phospholipase A2 activity in promoting and propagating vascular response to injury and atherogenesis in the diabetic state will be examined. In Project 3 the role of calcium-independent phospholipase A2 in facilitating capacitative calcium entry into insulin secreting cells and vascular smooth muscle cells will be identified. Clinical studies in Projects 2 and 4 include identification of alterations in the lipid composition of specific cellular elements in diabetic atherosclerotic plaques and investigation of both the importance of lipid second messenger generation in ischemic human myocardium and the role of hyperglycemia and hyperinsulinemia per se in the development of coronary atherosclerosis in human subjects. Collectively, the proposed studies represent a multidisciplinary approach from the laboratory to the clinical setting designed to identify a unifying glucose mediated mechanism underlying myocardial and vascular disease in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL057278-05
Application #
6184243
Study Section
Special Emphasis Panel (ZHL1-CSR-Y (M2))
Project Start
1996-09-30
Project End
2001-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
5
Fiscal Year
2000
Total Cost
$145,674
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Beirowski, Bogdan; Babetto, Elisabetta; Golden, Judith P et al. (2014) Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance. Nat Neurosci 17:1351-61
Lei, Xiaoyong; Bone, Robert N; Ali, Tomader et al. (2014) Evidence of contribution of iPLA2?-mediated events during islet ?-cell apoptosis due to proinflammatory cytokines suggests a role for iPLA2? in T1D development. Endocrinology 155:3352-64
Pacheco, Sophia A; Hsu, Fong-Fu; Powers, Katelyn M et al. (2013) MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis. J Biol Chem 288:24213-22
Lei, Xiaoyong; Bone, Robert N; Ali, Tomader et al. (2013) Genetic modulation of islet ?-cell iPLA?? expression provides evidence for its impact on ?-cell apoptosis and autophagy. Islets 5:29-44
Kuda, Ondrej; Pietka, Terri A; Demianova, Zuzana et al. (2013) Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages. J Biol Chem 288:15547-55
Yang, Kui; Dilthey, Beverly Gibson; Gross, Richard W (2013) Identification and quantitation of fatty acid double bond positional isomers: a shotgun lipidomics approach using charge-switch derivatization. Anal Chem 85:9742-50
Viader, Andreu; Sasaki, Yo; Kim, Sungsu et al. (2013) Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron 77:886-98
Kiebish, Michael A; Yang, Kui; Liu, Xinping et al. (2013) Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J Lipid Res 54:1312-25
Jenkins, Christopher M; Yang, Jingyue; Gross, Richard W (2013) Mechanism-based inhibition of iPLA2? demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition. Biochemistry 52:4250-63
Kiebish, Michael A; Yang, Kui; Sims, Harold F et al. (2012) Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency. J Biol Chem 287:25086-97

Showing the most recent 10 out of 180 publications